Results 191 to 200 of about 24,911 (203)

Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine

Leukemia and Lymphoma, 2008
Gautam Borthakur, Farhad Ravandi, Jean-Pierre J Issa   +2 more
exaly  

Decitabine in the treatment of myelodysplastic syndromes

Expert Review of Anticancer Therapy, 2010
Hagop M Kantarjian, Guillermo Garcia-Manero, Jean-Pierre J Issa   +2 more
exaly  

Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation, 2015
Iskra Pusic, Jaebok Choi, Mark A Fiala Msw   +2 more
exaly  

The hENT1 and DCK genes underlie the decitabine response in patients with myelodysplastic syndrome

Leukemia Research, 2015
Xin Du
exaly  

Decitabine

2011
openaire   +1 more source

Decitabine

Reactions Weekly, 2005
openaire   +1 more source

Decitabine

Reactions Weekly, 2010
openaire   +1 more source

Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells

Biomedicine and Pharmacotherapy, 2013
exaly  

Decitabin

2013
Strupp, Corinna, Lübbert, Michael, Wörmann, Bernhard, Platzbecker, Uwe, Braess, Jan, Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie, Deutschland. Gemeinsamer Bundesausschuss, Müller-Tidow, Carsten   +7 more
openaire   +1 more source

Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis

Annals of Oncology, 2013
exaly